Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia
NCT06363890 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2025-09-04
Summary
The study proposed here will determine the frequency and etiology of diarrhea in Australian adult tourists traveling to Southeast Asia, including Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Thailand, Timor-Leste, and Vietnam. The results from this study will inform the feasibility and design of subsequent clinical trials of travelers' diarrhea interventions in this population.
Conditions
- Travelers Diarrhea
Interventions
- DIAGNOSTIC_TEST
-
TAQMan Array Card
Real time PCR test to detect diarrheal pathogens.
Sponsors & Collaborators
-
Lumen Bioscience, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-20
- Primary Completion
- 2026-03-01
- Completion
- 2026-07-01
Countries
- Australia
Study Locations
More Related Trials
-
Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months
NCT03561181 ·Status: COMPLETED ·Phase: PHASE1
-
Optimising Rotavirus Vaccine in Aboriginal Children
NCT02941107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Special Drug Use Investigation for ROTARIX®
NCT01636739 ·Status: COMPLETED
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED
-
Phase III Study of Liquid Formulation of ROTAVIN
NCT03703336 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants
NCT03507738 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam
NCT03367559 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years
NCT04026984 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Drug Use Investigation for ROTARIX®
NCT01636193 ·Status: COMPLETED
-
Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea
NCT01060748 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
NCT01575197 ·Status: COMPLETED ·Phase: PHASE4
-
Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
NCT01738074 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years
NCT04027894 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
ROTATEQ™ Post-Marketing Surveillance in the Philippines
NCT01357174 ·Status: TERMINATED
-
Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines
NCT03897309 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years Old
NCT04865497 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
NCT01266850 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years
NCT05156528 ·Status: UNKNOWN ·Phase: PHASE3
-
ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage
NCT06882070 ·Status: COMPLETED
-
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
NCT06350058 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
NCT00653198 ·Status: COMPLETED
-
Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults
NCT01739231 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants
NCT00655187 ·Status: COMPLETED
-
Environmental Surveillance (ES) for Polio and AMR Using the TaqMan Array Card
NCT03818477 ·Status: UNKNOWN
-
A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E
NCT01305109 ·Status: UNKNOWN ·Phase: PHASE3